Zboralski D

References (2)

Title : Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using (177)Lu-FAP-2286: First-in-Humans Results - Baum_2022_J.Nucl.Med_63_415
Author(s) : Baum RP , Schuchardt C , Singh A , Chantadisai M , Robiller FC , Zhang J , Mueller D , Eismant A , Almaguel F , Zboralski D , Osterkamp F , Hoehne A , Reineke U , Smerling C , Kulkarni HR
Ref : J Nucl Med , 63 :415 , 2022
Abstract :
PubMedSearch : Baum_2022_J.Nucl.Med_63_415
PubMedID: 34168013

Title : Preclinical evaluation of FAP-2286 for fibroblast activation protein targeted radionuclide imaging and therapy - Zboralski_2022_Eur.J.Nucl.Med.Mol.Imaging_49_3651
Author(s) : Zboralski D , Hoehne A , Bredenbeck A , Schumann A , Nguyen M , Schneider E , Ungewiss J , Paschke M , Haase C , von Hacht JL , Kwan T , Lin KK , Lenore J , Harding TC , Xiao J , Simmons AD , Mohan AM , Beindorff N , Reineke U , Smerling C , Osterkamp F
Ref : Eur J Nucl Med Mol Imaging , 49 :3651 , 2022
Abstract :
PubMedSearch : Zboralski_2022_Eur.J.Nucl.Med.Mol.Imaging_49_3651
PubMedID: 35608703